Citations

Showing 10 of 108104 citations.

Review of the indications, methods, and clinical utility of anorectal manometry and the rectal balloon expulsion test
Bharucha, Adil E. , Malcolm, Allison , Lee, Tae Hee , Scott, S. Mark , Rao, Satish S.C. , Basilisco, Guido , Hoy, Matthew B. , Scott, S Mark , Rao, Satish , Malcolm, Allison , Basilisco, Guido

Mayo Clinic

Neurogastroenterology & Motility | February 27, 2022 | Volume: 34 | Issue: 9 | Pages: No page available

10.1111/nmo.14335 | PMID 35220645 Get It

Abstract Background Anorectal manometry (ARM) comprehensively assesses anorectal sensorimotor functions. Purpose This review examines the indications, techniques, interpretation, strengths, and weaknesses of high‐resolution ARM (HR‐ARM), 3‐dimensional high‐resolution anorectal manometry (3D‐HR‐ARM), and portable ARM, and other assessments (i.e., rectal sensation and rectal balloon expulsion test) that are performed alongside manometry. It is based on a literature search of articles related to ARM in adults. HR‐ARM and 3D‐HR‐ARM are useful for diagnosing defecatory disorders (DD), to identify anorectal sensorimotor dysfunction and guide management in patients with fecal incontinence (FI), constipation, megacolon, and megarectum; and to screen for anorectal structural (e.g., rectal intussusception) abnormalities. The rectal balloon expulsion test is a useful, low‐cost, radiation‐free, outpatient assessment tool for impaired evacuation that is performed and interpreted in conjunction with ARM. The anorectal function tests should be interpreted with reference to age‐ and sex‐matched normal values, clinical features, and results of other tests. A larger database of technique‐specific normal values and newer paradigms of analyzing anorectal pressure profiles will increase the precision and diagnostic utility of HR‐ARM for identifying abnormal mechanisms of defecation and continence.
Longitudinal trajectories of treatment burden: A prospective survey study of adults living with multiple chronic conditions in the midwestern United States
Eton, David T. , Anderson, Roger T. , Rogers, Elizabeth A. , Lee, Minji K. , Sauver, Jennifer L. St. , Linzer, Mark

Mayo Clinic

Journal of Multimorbidity and Comorbidity | February 27, 2022 | Volume: 12 | Issue: No issue available | Pages: No page available

10.1177/26335565221081291 | PMID 35586037 Get It

Objectives Determine whether there are different longitudinal patterns of treatment burden in people living with multiple chronic conditions (MCC) and, if so, explore predictors that might reveal potential routes of intervention. Methods We analyzed data from a prospective mailed survey study of 396 adults living with MCC in southeastern Minnesota, USA. Participants completed a measure of treatment burden, the Patient Experience with Treatment and Self-management (PETS), and valid measures of health-related and psycho-social concepts at baseline, 6, 12, and 24 months. Latent class growth mixture modeling (LCGM) determined trajectories of treatment burden in two summary index scores of the PETS: Workload and Impact. Multivariable logistic regressions were used to identify independent predictors of the trajectories. Results LCGM supported a 2-class model for PETS Workload, including a group of consistently high workload ( N = 69) and a group of consistently low workload ( N = 311) over time. A 3-class model was supported for PETS Impact, including groups of consistently high impact ( N = 62), consistently low impact ( N = 278), and increasing impact ( N = 51) over time. Logistic regression analyses showed that the following factors were associated with patterns of consistently high or increasing treatment burden over time: lower health literacy, lower self-efficacy, more interpersonal challenges with others, and worse subjective reports of physical and mental health (all p < .05). Conclusions Different longitudinal patterns of treatment burden exist among people with MCC. Raising health literacy, enhancing self-efficacy, and lessening the effects of negative social interactions might help reduce treatment burden.
In vivo assessment of hypertensive nephrosclerosis using ultrasound localization microscopy
Qiu, Lanyan , Zhang, Jingke , Yang, Yi , Zhang, Hong , Lee, Fu‐Feng , He, Qiong , Huang, Lijie , Luo, Jianwen , Zhang, Jingke , Huang, Chengwu , Qian, Linxue

Mayo Clinic

Medical Physics | February 26, 2022 | Volume: 49 | Issue: 4 | Pages: 2295-2308

10.1002/mp.15583 | PMID 35218672 Get It

AbstractPurposeAs a typical chronic kidney disease (CKD), hypertensive nephrosclerosis (HN) is a common syndrome of hypertension, characterized by chronic kidney microvascular damage. Early diagnosis of microvascular damage using conventional ultrasound imaging encounters challenges in sensitivity and specificity owing to the inherent diffraction limit. Ultrasound localization microscopy (ULM) has been developed to obtain microvasculature and microvascular hemodynamics within the kidney, and would be a promising tool for the early diagnosis of CKD.MethodsIn this study, the advantage of quantitative indexes obtained by using ULM (mean arterial blood flow speeds of different segments of interlobular arteries) over indexes obtained using conventional clinical serum (β2‐microglobulin, serum urea nitrogen, and creatinine) and urine (24‐h urine volume and urine protein) tests and ultrasound Doppler imaging (peak systolic velocity [PSV], end‐diastolic velocity [EDV], and resistance index [RI]) and contrast‐enhanced ultrasound imaging (CEUS; rise time [RT], peak intensity [IMAX], mean transit time [mTT], and area under the time‐intensity curve [AUC]) for early diagnosis of HN were investigated. Examinations were carried out on six spontaneously hypertensive rats (SHR) and five normal Wistar–Kyoto (WKY) rats at the age of 10 weeks.ResultsThe experimental results show that the indicators derived from conventional clinical inspections (serum and urine tests) and ultrasound imaging (PSV, EDV, RI, RT, IMAX, mTT, and AUC) do not show significant difference between hypertensive and healthy rats (p > 0.05), while the TTP of the SHR group (28.52 ± 5.52 s) derived from CEUS is significantly higher than that of the WKY group (18.68 ± 7.32 s; p < 0.05). The mean blood flow speed in interlobular artery of SHR (12.47 ± 1.06 mm/s) derived from ULM is significantly higher than that of WKY rats (10.13 ± 1.17 mm/s; p < 0.01).ConclusionThe advantages of ULM over conventional clinical inspections and ultrasound imaging methods for early diagnosis of HN were validated. The quantitative results show that ULM can effectively diagnose HN at the early stage by detecting the blood flow speed changes of interlobular arteries. ULM may promise a reliable technique for early diagnosis of HN in the future.
Pre- and Post-Injection Needle Pain in Patients Undergoing First Intracavernosal Injection
Baird, Bryce , Wajswol, Ethan , Ericson, Christian , Anderson, Augustus, Broderick, Gregory, Anderson, Augustus, Broderick, Gregory A.

Mayo Clinic

The Journal of Sexual Medicine | February 26, 2022 | Volume: 19 | Issue: 4 | Pages: 590-593

10.1016/j.jsxm.2022.01.520 | PMID 35227620 Get It

ABSTRACTBackgroundIntracavernosal injections (ICI) are a well-established treatment option for men with erectile dysfunction (ED); however, the anticipation of pain with injection remains a significant barrier to the use of ICI.AimTo evaluate the patient-anticipated degree of pain versus the experienced degree of pain pre- and post-ICI in men undergoing their first injection with an erectile agent.MethodsWe studied 51 patients who underwent their first ICI in our men’s health clinic. Anticipated needle-associated pain was judged with a pre-injection score, and pain experienced during the injection was judged with a post-injection score. All patients graded their pre- and post-ICI pain using a standard 10-point scale (0–10).OutcomesPre- and post-ICI pain was defined with the visual analogue scale (0–10) in men undergoing their first penile injection.ResultsMedians and interquartile ranges (IQRs) of the patients’ age [65 years (54.5–68.0)], pre-injection pain [5 (4–7)], and post-injection pain [1 (1–2)] were recorded. Most men in the study had erectile dysfunction (68.6%) and/or Peyronie’s Disease (64.7%). The average pre-injection prediction pain score was 5.45 ± 2.15; the average post-injection perceived pain score was 1.20 ± 0.73. Thus, there was an average discrepancy of over 4 points in predicted pain vs perceived pain. A paired t-test was performed which showed a statistically significant difference between pre- and post-injection scores (P &lt; .05). A Wilcoxson Signed Rank Test showed statistical significance in the difference between pre- and post-injection pain scores (P &lt; .05).Clinical ImplicationsICI is a safe, effective treatment for patients with ED and is associated with significantly less pain than is anticipated by patients.Strengths & LimitationsThis is the first report to describe the discrepancy between pre-ICI anticipated pain and post-ICI experienced pain. Limitations include an overall small sample size.ConclusionPatients experience significantly less pain with ICI than they anticipate having. This represents an important factor to consider when counseling patients about available ED treatments.
Metastatic Colorectal Cancer Outcomes by Age Among ARCAD First- and Second-Line Clinical Trials
McCleary, Nadine J. , Harmsen, William S. , Haakenstad, Ellana , Cleary, James M. , Meyerhardt, Jeffrey A. , Zalcberg, John , Adams, Richard , Grothey, Axel , Sobrero, Alberto , Cutsem, Eric Van , Goldberg, Richard M. , Seymour, Michel , Giantonio, Bruce J. , Rothenberg, Mace L., Koopman, Miriam , Schmoll, Hans‐Joachim , Pitot, Henry C., Hoff, Paulo M. , Souglakos, John , Bokemeyer, Carsten , Heinemann, Volker , Chibaudel, Benoist , deGramont, Aimery, Shi, Qian , Sobrero, Alberto F , Van Cutsem, Eric , Peeters, Marc , Tabernero, Josep , Seymour, Matthew T , Saltz, Leonard , Koopman, Miriam , Tebbutt, Niall C , Bokemeyer, Carsten , Heinemann, Volker , Yoshino, Takayuki , De Gramont, Aimery , Shi, Qian , Lichtman, Stuart M , Meyerhardt, Jeffrey A , Zalcberg, John , Adams, Richard , Schmoll, Hans-Joachim , Chibaudel, Benoist , Peeters, Marc , Tabernero, Josep , Saltz, Leonard B. , Arnold, Dirk , Tebbutt, Niall C. , Masi, Gianluca , Yoshino, Takayuki , Gramont, Aimery de , Lichtman, Stuart M.

Mayo Clinic

JNCI Cancer Spectrum | February 25, 2022 | Volume: 6 | Issue: 2 | Pages: No page available

10.1093/jncics/pkac014 | PMID 35603849 Get It

Abstract Background We evaluated the time to progression (TTP) and survival outcomes of second-line therapy for metastatic colorectal cancer among adults aged 70 years and older compared with younger adults following progression on first-line clinical trials. Methods Associations between clinical and disease characteristics, time to initial progression, and rate of receipt of second-line therapy were evaluated. TTP and overall survival (OS) were compared between older and younger adults in first- and second-line trials by Cox regression, adjusting for age, sex, Eastern Cooperative Oncology Group Performance Status, number of metastatic sites and presence of metastasis in the lung, liver, or peritoneum. All statistical tests were 2-sided. Results Older adults comprised 16.4% of patients on first-line trials (870 total older adults aged &gt;70 years; 4419 total younger adults aged ≤70 years, on first-line trials). Older adults and those with Eastern Cooperative Oncology Group Performance Status &gt;0 were less likely to receive second-line therapy than younger adults. Odds of receiving second-line therapy decreased by 11% for each additional decade of life in multivariable analysis (odds ratio = 1.11, 95% confidence interval = 1.02 to 1.21, P = .01). Older and younger adults enrolled in second-line trials experienced similar median TTP and median OS (median TTP = 5.1 vs 5.2 months, respectively; median OS = 11.6 vs 12.4 months, respectively). Conclusions Older adults were less likely to receive second-line therapy for metastatic colorectal cancer, though we did not observe a statistical difference in survival outcomes vs younger adults following second-line therapy. Further study should examine factors affecting decisions to treat older adults with second-line therapy. Inclusion of geriatric assessment may provide better criteria regarding the risks and benefits of second-line therapy.
Beta-Blockers for Treatment of Hypertension: Where Do They Fit?
Hommos, Musab S. , Kim, Jee H, Hommos, Musab S , Kim, Jee Hyun

Mayo Clinic

American Journal of Hypertension | February 25, 2022 | Volume: 35 | Issue: 7 | Pages: 587-589

10.1093/ajh/hpac030 | PMID 35302582 Get It

The neuromuscular fellowship portal and match
London, Zachary , Gable, Karissa , Govindarajan, Ragav, Guidon, Amanda C. , Gwathmey, Kelly , Hehir, Michael K. , Imperioli, Matthew, Laughlin, Ruple S. , Price, Raymond S. , Sakamuri, Sarada, Sokol, Jacob, Baer, Michael, London, Zachary N

Mayo Clinic

Muscle & Nerve | February 25, 2022 | Volume: 65 | Issue: 6 | Pages: 640-645

10.1002/mus.27525 | PMID 35213933 Get It

AbstractFor many years, Neuromuscular Medicine programs lacked a standardized means of handling fellowship applications and offering positions. Programs interviewed applicants and made offers as early as the first half of Post Graduate Year 3 (PGY3), a suboptimal timeline for applicants who may have had little prior exposure to neuromuscular or electrodiagnostic medicine. In 2021, the American Association of Neuromuscular & Electrodiagnostic Medicine (AANEM) developed the Neuromuscular Fellowship Portal to standardize a later timeline and establish a process for fellowship applications and offers. In its first year, the Neuromuscular Fellowship Portal used a unique one‐way match, in which the portal released serial offers to applicants based on rank order lists submitted by programs. Fifty‐two Neuromuscular Medicine programs and seven electromyography (EMG)‐focused Clinical Neurophysiology programs participated. Sixty‐eight positions were filled, a similar number to previous years. A survey of fellowship directors and applicants following this process showed overwhelming support for the standardized timeline and application portal, but all program directors and most applicants favored moving to a traditional match. To maintain the existing application timeline and minimize costs for all parties, the AANEM Neuromuscular Fellowship Portal will host a two‐way match, based on existing commercial match algorithms, in 2022. A match will afford a fair and efficient process for all involved. Both Neuromuscular Medicine and EMG‐focused Clinical Neurophysiology programs will be encouraged to participate. The process undertaken by the AANEM can stand as an example for other neurologic subspecialties who are interested in standardizing their application timeline.
Screening and enrollment of underrepresented ethnocultural and educational populations in the Alzheimer's Disease Neuroimaging Initiative (ADNI)
Ashford, Miriam T. , Raman, Rema , Miller, Garrett, Donohue, Michael , Okonkwo, Ozioma C. , Nosheny, Rachel L. , Coker, Godfrey, Petersen, Ronald C. , Aisen, Paul , Weiner, Michael W. , Initiative, the Alzheimer's Disease Neuroimaging, Donohue, Michael C , Mindt, Mónica Rivera , Initiative, the Alzheimer's Disease Neuroimaging

Mayo Clinic

Alzheimer's & Dementia | February 25, 2022 | Volume: 18 | Issue: 12 | Pages: 2603-2613

10.1002/alz.12640 | PMID 35213778 Get It

AbstractIntroductionAn analysis of the ethnocultural and socioeconomic composition of Alzheimer's Disease Neuroimaging Initiative (ADNI) participants is needed to assess the generalizability of ADNI data to diverse populations.MethodsADNI data collected between October 2004 and November 2020 were used to determine ethnocultural and educational composition of the sample and differences in the following metrics: screening, screen fails, enrollment, biomarkers.ResultsOf 3739 screened individuals, 11% identified as being from ethnoculturally underrepresented populations (e.g., Black, Latinx) and 16% had <12 years of education. Of 2286 enrolled participants, 11% identified as ethnoculturally underrepresented individuals and 15% had <12 years of education. This participation is considerably lower than US Census data for adults 60+ (ethnoculturally underrepresented populations: 25%; <12 years of education: 4%). Individuals with <12 years of education failed screening at a higher rate.DiscussionOur findings suggest that ADNI results may not be entirely generalizable to ethnoculturally diverse and low education populations.
Does dengue and COVID‐19 co‐infection have worse outcomes? A systematic review of current evidence
El‐Qushayri, Amr Ehab , Kamel, Ahmed Mostafa Ahmed , Ghozy, Sherief , El‐Qushayri, Amr Ehab , Reda, Abdullah , Ghozy, Sherief , El‐Qushayri, Amr Ehab , Reda, Abdullah

Mayo Clinic

Reviews in Medical Virology | February 25, 2022 | Volume: 32 | Issue: 5 | Pages: No page available

10.1002/rmv.2339 | PMID 35213764 Get It

Abstract In dengue‐endemic regions, the co‐infection with SARS‐CoV‐2 and dengue is a significant health concern. Therefore, we performed a literature search for relevant papers in seven databases on 26 Spetember 2021. Out of 24 articles, the mortality rate and intensive care unit (ICU) admission were 19.1% and 7.8%, respectively. The mean hospital stay was 11.4 days. In addition, we identified two pregnancies with dengue and COVID‐19 co‐infection; one ended with premature rupture of membrane and intrauterine growth restriction fetus, while the other one ended with maternal mortality and intrauterine fetal death. COVID‐19 and dengue co‐infection had worse outcomes regarding mortality rates, ICU admission, and prolonged hospital stay. Thus, wise‐decision management approaches should be adequately offered to these patients to enhance their outcomes. Establishing an early diagnosis might be the answer to reducing the estimated significant burden of these conditions.
85-Year-Old Postsurgical Complex Patient Successfully Managed Remotely at the Novel Mayo Clinic’s Hospital at Home
Paulson, Margaret R. , Torres‐Guzman, Ricardo A. , Ávila, Francisco R. , Maita, Karla C. , Garcia, John P. , Eldaly, Abdullah S. , Serrano, Luiza Palmieri , Forte, Antonio J. , Thompson, Jonathan C. , Maniaci, Michael J. , Maita, Karla , Eldaly, Abdullah , Palmieri-Serrano, Luiza , Forte, Antonio Jorge , Torres, Ricardo A , Maniaci, Michael J , Avila, Francisco R , Garcia, John P , Paulson, Margaret R

Mayo Clinic

Case Reports in Vascular Medicine | February 25, 2022 | Volume: 2022 | Issue: No issue available | Pages: 1-5

10.1155/2022/1439435 | PMID 35251735 Get It

An 85-year-old male presented to the podiatry clinic following a 1st to 5th left toe amputation as a complication of severe peripheral arterial disease and nonhealing wound despite endovascular intervention with an angiogram. At the visit, cellulitis with gangrene of the surgical site was noted. The patient was admitted to the brick and mortar (BAM) hospital and taken to surgery for a transmetatarsal amputation of the left limb. In the immediate postoperative period, the incisional margins appeared dusky creating concern for flap viability. The medical team recommended a vascular bypass versus a below-knee amputation. However, given the age, comorbidities, and nutritional status, the family refused further surgical intervention. As such, Mayo Clinic’s home hospital program, Advanced Care at Home (ACH), was consulted for continued nonsurgical acute management at home. The patient was transferred to ACH and transported home three days after BAM admission to continue IV antibiotic therapy and wound care. Discharge from ACH occurred 11 days after admission to the BAM hospital. This case highlights the importance of developing health care alternatives to traditional hospitalization and demonstrates that ACH can manage highly complex, elder postoperative patients from the comfort of their homes.